Actelion (English Wikipedia)

Wolters Kuwer Legal & Regulatory US (2016). "Asahi Kasei Pharma Corp. v. Actelion Ltd.". Torts. Casenote Legal Briefs (11th ed.). New York: Wolters Kluwer. ISBN 978-1-4548-7973-2 – via Google Books. Case reference: 222 Cal. App. 4th 945 (2014)
Epstein, Richard Allen; Sharkey, Catherine (2016). "14. Economic Harms". Cases and Materials on Torts. Aspen Casebook Series (11th ed.). New York: Wolters Kluwer. Section B. Inducement of Breach of Contract: Asahi Kasei Pharma Corp. v. Actelion Ltd. ISBN 978-1-4548-7746-2 – via Google Books.

businessweek.com (Global: 712^th place; English: 526^th place)

investing.businessweek.com

"ACTELION LTD-REG (ATLN:VX)". Bloomberg Businessweek (Stock Quote & Company Profile). Archived from the original on 29 April 2010. Retrieved 8 March 2011.

doi.org (Global: 2^nd place; English: 2^nd place)

Perros, Frédéric; Dorfmüller, Peter; Montani, David; Hammad, Hamida; Waelput, Wim; Girerd, Barbara; Raymond, Nicolas; Mercier, Olaf; Mussot, Sacha; Cohen-Kaminsky, Sylvia; Humbert, Marc; Lambrecht, Bart N. (2012). "Pulmonary Lymphoid Neogenesis in Idiopathic Pulmonary Arterial Hypertension". American Journal of Respiratory and Critical Care Medicine. 185 (3): 311–321. doi:10.1164/rccm.201105-0927OC. PMID 22108206. Supported in part by the Legs Poix, the Université Paris-Sud, INSERM, an Actelion Endothelin Research Award (AERA 2007-010)...
Schmidt, Charlie (1 February 2007). "Profile: Jean-Paul Clozel". Nature Biotechnology. 25 (2): 155. doi:10.1038/nbt0207-155. PMID 17287737. S2CID 919216.
Dyer, Owen (10 December 2018). "Actelion Pharmaceuticals pays 360m to settle US government claims of kickbacks to patients". BMJ. 363 k5231. doi:10.1136/bmj.k5231. PMID 30530812. S2CID 54474524 – via FIU library.

europa.eu (Global: 68^th place; English: 117^th place)

ema.europa.eu

"Tracleer". Medicines (EPAR). European Medicines Agency. 3 December 2019. Retrieved 23 February 2020.
"Zavesca". Medicines (EPAR). European Medicines Agency. 6 February 2020. Retrieved 23 February 2020.
"Ventavis". Medicines (EPAR). European Medicines Agency. 10 October 2019. Retrieved 23 February 2020.

fiercebiotech.com (Global: low place; English: 8,828^th place)

Taylor, Nick Paul (17 April 2018). "Johnson & Johnson scraps phase 3 antibiotic program acquired in $30B Actelion takeover". FierceBiotech. Framingham, Massachusetts: Questex. Retrieved 5 July 2018.

finde-offen.ch (Global: low place; English: low place)

"Actelion Pharma Switzerland Ltd Öffnungszeiten".

ft.com (Global: 210^th place; English: 157^th place)

Crow, David; Atkins, Ralph (26 January 2017). "Johnson & Johnson to buy Swiss biotech company Actelion for $30bn". Financial Times. Retrieved 21 October 2021.

galegroup.com (Global: 1,830^th place; English: 1,066^th place)

go.galegroup.com

"Actelion reports data from Phase IV trial for PAH". R & D Focus Drug News. 18 March 2019.

idorsia.com (Global: low place; English: low place)

Clozel, Jean-Paul. "About Idorsia history". www.idorsia.com. Retrieved 19 August 2018.

life-sciences-europe.com (Global: low place; English: low place)

"Actelion Pharmaceuticals Deutschland GmbH". Retrieved 17 February 2025.
"Actelion Pharmaceuticals Austria GmbH". Retrieved 17 February 2025.
"Actelion Paris Organisation SAS".
"Actelion Pharmaceuticals UK Ltd". Retrieved 17 February 2025.

news-medical.net (Global: 8,069^th place; English: 7,681^st place)

"FDA approves brand name VELETRI for Actelion's epoprostenol for injection therapy". News Medical Lifesciences (Press release). Actelion. 26 August 2010. Retrieved 23 February 2020 – via AZoNetworks.^{[self-published source]}

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Perros, Frédéric; Dorfmüller, Peter; Montani, David; Hammad, Hamida; Waelput, Wim; Girerd, Barbara; Raymond, Nicolas; Mercier, Olaf; Mussot, Sacha; Cohen-Kaminsky, Sylvia; Humbert, Marc; Lambrecht, Bart N. (2012). "Pulmonary Lymphoid Neogenesis in Idiopathic Pulmonary Arterial Hypertension". American Journal of Respiratory and Critical Care Medicine. 185 (3): 311–321. doi:10.1164/rccm.201105-0927OC. PMID 22108206. Supported in part by the Legs Poix, the Université Paris-Sud, INSERM, an Actelion Endothelin Research Award (AERA 2007-010)...
Schmidt, Charlie (1 February 2007). "Profile: Jean-Paul Clozel". Nature Biotechnology. 25 (2): 155. doi:10.1038/nbt0207-155. PMID 17287737. S2CID 919216.
Dyer, Owen (10 December 2018). "Actelion Pharmaceuticals pays 360m to settle US government claims of kickbacks to patients". BMJ. 363 k5231. doi:10.1136/bmj.k5231. PMID 30530812. S2CID 54474524 – via FIU library.

nzz.ch (Global: 687^th place; English: 2,985^th place)

Grundlehner, Werner (5 July 2017). "Was plant das Ehepaar Clozel? | NZZ". Neue Zürcher Zeitung (in German). Retrieved 21 October 2021.

pah-info.com (Global: low place; English: low place)

"Actelion affiliates". Archived from the original on 8 March 2011. Retrieved 8 March 2011.

rencontre-innovation.com (Global: low place; English: low place)

"Prix Hermès". Archived from the original on 21 December 2010.

reuters.com (Global: 49^th place; English: 47^th place)

Miller, John; Arnold, Paul (26 January 2017). "Johnson & Johnson to buy Actelion for $30 billion, spin off R&D unit". Reuters. Retrieved 26 January 2017.

sec.gov (Global: 572^nd place; English: 436^th place)

"UNITED STATES SECURITIES AND EXCHANGE COMMISSION, Commission file number 1-3215, Johnson & Johnson jnj-20231231". www.sec.gov. Retrieved 12 November 2024.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Schmidt, Charlie (1 February 2007). "Profile: Jean-Paul Clozel". Nature Biotechnology. 25 (2): 155. doi:10.1038/nbt0207-155. PMID 17287737. S2CID 919216.
Dyer, Owen (10 December 2018). "Actelion Pharmaceuticals pays 360m to settle US government claims of kickbacks to patients". BMJ. 363 k5231. doi:10.1136/bmj.k5231. PMID 30530812. S2CID 54474524 – via FIU library.

sitemorse.ch (Global: low place; English: low place)

"Prize for Website" (PDF). Archived from the original (PDF) on 23 March 2012.

six-swiss-exchange.com (Global: low place; English: low place)

"Swiss Market Index". 13 May 2024.

thepharmaletter.com (Global: low place; English: low place)

"The Pharmaletter".

ubs.com (Global: 9,002^nd place; English: 7,208^th place)

"UBS". Archived from the original on 5 September 2014. Retrieved 27 August 2014.

web.archive.org (Global: 1^st place; English: 1^st place)

"Acetelion Annual Business Report 2016" (PDF). Archived from the original (PDF) on 10 November 2019.
"ACTELION LTD-REG (ATLN:VX)". Bloomberg Businessweek (Stock Quote & Company Profile). Archived from the original on 29 April 2010. Retrieved 8 March 2011.
"Actelion affiliates". Archived from the original on 8 March 2011. Retrieved 8 March 2011.
"Actelion company homepage". Archived from the original on 22 February 2011. Retrieved 7 March 2011.
"UBS". Archived from the original on 5 September 2014. Retrieved 27 August 2014.
"Prix Hermès". Archived from the original on 21 December 2010.
"Prize for Website" (PDF). Archived from the original (PDF) on 23 March 2012.

wsj.com (Global: 79^th place; English: 65^th place)

Roland, Denise; D. Rockoff, Jonathan (26 January 2017). "Johnson & Johnson to Acquire Actelion in $30 Billion Deal". The Wall Street Journal. Retrieved 27 January 2017.

Actelion (English Wikipedia)

actelion.com (Global: low place; English: low place)

bmj.com (Global: 1,226th place; English: 1,421st place)

books.google.com (Global: 3rd place; English: 3rd place)

businessweek.com (Global: 712th place; English: 526th place)

investing.businessweek.com

doi.org (Global: 2nd place; English: 2nd place)

europa.eu (Global: 68th place; English: 117th place)

ema.europa.eu

fiercebiotech.com (Global: low place; English: 8,828th place)

finde-offen.ch (Global: low place; English: low place)

ft.com (Global: 210th place; English: 157th place)

galegroup.com (Global: 1,830th place; English: 1,066th place)

go.galegroup.com

idorsia.com (Global: low place; English: low place)

life-sciences-europe.com (Global: low place; English: low place)

news-medical.net (Global: 8,069th place; English: 7,681st place)

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

nzz.ch (Global: 687th place; English: 2,985th place)

pah-info.com (Global: low place; English: low place)

rencontre-innovation.com (Global: low place; English: low place)

reuters.com (Global: 49th place; English: 47th place)

sec.gov (Global: 572nd place; English: 436th place)

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

sitemorse.ch (Global: low place; English: low place)

six-swiss-exchange.com (Global: low place; English: low place)

thepharmaletter.com (Global: low place; English: low place)

ubs.com (Global: 9,002nd place; English: 7,208th place)

web.archive.org (Global: 1st place; English: 1st place)

wsj.com (Global: 79th place; English: 65th place)

bmj.com (Global: 1,226^th place; English: 1,421^st place)

books.google.com (Global: 3^rd place; English: 3^rd place)

businessweek.com (Global: 712^th place; English: 526^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

europa.eu (Global: 68^th place; English: 117^th place)

fiercebiotech.com (Global: low place; English: 8,828^th place)

ft.com (Global: 210^th place; English: 157^th place)

galegroup.com (Global: 1,830^th place; English: 1,066^th place)

news-medical.net (Global: 8,069^th place; English: 7,681^st place)

nih.gov (Global: 4^th place; English: 4^th place)

nzz.ch (Global: 687^th place; English: 2,985^th place)

reuters.com (Global: 49^th place; English: 47^th place)

sec.gov (Global: 572^nd place; English: 436^th place)

semanticscholar.org (Global: 11^th place; English: 8^th place)

ubs.com (Global: 9,002^nd place; English: 7,208^th place)

web.archive.org (Global: 1^st place; English: 1^st place)

wsj.com (Global: 79^th place; English: 65^th place)